First test to detect recently discovered autoimmune disease associated with testicular cancer

Mayo Clinic Laboratories has launched a first-of-its-kind test to detect an autoimmune disease called testicular cancer-associated paraneoplastic encephalitis. The test, available nationally and internationally, detects the Kelch-like protein 11 antibody, or KLHL11, and is a result of the breakthrough study from 2019 that discovered the disease. This test has already provided patients, such as Steven Wopperer of [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news